NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Oracle Corporation (“Oracle” or the “Company”) (NYSE: ORCL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against uniQure N.V. (“uniQure” or the “Company”) (NASDAQ: QURE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Nasdaq and US indices rally as Nvidia and tech stocks surge on Trump de-escalation signals, boosting market sentiment today.

Shares of Roku Inc (NASDAQ:ROKU) surged more than 8% Tuesday following a Jefferies note highlighting the revenue potential from the company's upcoming Home Screen refresh. Jefferies sees the refresh as a “widely cited catalyst” that could unlock meaningful incremental revenue, particularly through the introduction of biddable performance tiles, or auction-based ad units allowing content partners to bid for prominent Home Screen placement based on outcomes such as app opens or subscriptions.

Biogen Inc. (BIIB) Discusses Proposed Acquisition of Apellis and Strategic Growth Objectives Transcript

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Apple is reportedly stepping up efforts to crack down on vibe coding services. As The Information reported Monday (March 30), the tech giant recently removed one such app from its App Store for breaching its rules.

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

New York, New York--(Newsfile Corp. - March 31, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lufax Holding Ltd (NYSE: LU) between April 7, 2023 and January 26, 2025, both dates inclusive (the "Class Period"), of the important May 20, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Lufax securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Navan, Inc. (NASDAQ: NAVN) and Corcept Therapeutics Incorporated (NASDAQ: CORT). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Plug Power (PLUG) To Contact Him Directly To Discuss Their Options

Amazon has reached a settlement with the National Labor Relations Board in response to charges filed by the Teamsters and some employees alleging it retaliated against striking workers. The Teamsters alleged Amazon illegally docked employees' unpaid time off after they walked off the job.

Oracle is reportedly moving forward with layoffs as the software giant looks to restructure its workforce amid an investment in building out AI infrastructure.

UBS has outlined its preferred stock picks across the technology, media and telecommunications (TMT) sectors, highlighting companies where its analysts believe market expectations diverge meaningfully from underlying fundamentals. In business and professional services, Accenture PLC (NYSE:ACN) is identified as the firm's top choice.

LONGVIEW, Texas, March 31, 2026 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Friedman Industries, Incorporated, (NASDAQ/GS: FRD) a Texas-based company engaged in metals processing, pipe manufacturing, and metals distribution, declared on March 31, 2026, a cash dividend of $0.04 per share on the Common Stock of the Company. The Company will pay the cash dividend on May 22, 2026 to shareholders of record at the close of business on April 24, 2026.

Two crashes when Ford's BlueCruise system was engaged left three people dead.

NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ODDITY Tech Ltd. (“Oddity” or the “Company”) (NASDAQ: ODD) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02046, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Oddity securities between February 26, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants' violations of the federal …

BOCA RATON, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed its Annual Report on Form 10-K for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The report is available on the Company's website, www.lixte.com, and on the SEC's website, www.sec.gov.

Sara Awad from Tech Contrarians explains tech dynamics, geopolitical factors and increased investor scrutiny. AI infrastructure buildout continues, but supply chain risks—especially helium and energy bottlenecks—remain critical for TSMC, SK Hynix, Samsung, and broader tech.